Jena Bioscience
Private Company
Funding information not available
Overview
Jena Bioscience GmbH is a well-established, privately-held supplier of specialized reagents, kits, and consumables for life science research, with a strong focus on nucleotides, molecular biology, and structural biology techniques like cryo-electron microscopy. The company leverages a product-centric business model, generating revenue through direct sales and a global distributor network. Its strategic emphasis on high-growth areas like CRISPR, synthetic biology, and point-of-care diagnostics (e.g., RT-LAMP kits) positions it within key innovative research trends. A notable differentiator is its 'Search Citations' feature, which uses Bioz to showcase peer-reviewed publications citing its products, building scientific credibility and trust with its customer base.
Technology Platform
Portfolio of specialized research reagents, kits, and consumables for molecular biology, structural biology (including Quantifoil® cryo-EM grids), and synthetic biology. Offers custom synthesis, bulk/OEM production, and the LEXSY protein expression system.
Opportunities
Risk Factors
Competitive Landscape
Jena Bioscience competes in a fragmented but tough market dominated by giants like Thermo Fisher, Merck, and Danaher. It differentiates through deep specialization in niches like high-quality nucleotides and cryo-EM grids (Quantifoil®), a focus on product quality and scientific validation via citations, and flexibility in custom and bulk services that larger players may not offer as readily.